A research team from the LKS Faculty of Medicine at HKUMed has identified an unexpected driver of cancer immunotherapy ...
C-mo has announced an extension to its seed investment round. The round totals €4.8M, with Novalis Biotech as a new investor.
ExeGi Pharma LLC says the FDA has cleared its Investigational New Drug application for its biologic drug candidate, EXE-346.
Sysnav Healthcare and Roche have partnered to develop standard outcome measurements in diseases associated with movement ...
Orbsen Therapeutics has announced what it says are encouraging headline interim results from its clinical trial for diabetic kidney disease.
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been enrolled in a phase 1a/b study.
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application of exa-cel for the treatment of ...
Ubiquigent is supporting the University of Glasgow to study USP30, a DUB implicated in neurodegenerative, renal, and ...
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi in the ...
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell ...
University College London has received funding to progress two new therapies that could help transform the lives of those ...
MedUni Vienna's Department of Laboratory Medicine has uncovered a mechanism that plays a role in alcohol-related liver ...